SOURCE: MarketResearch.com

MarketResearch.com

April 11, 2011 08:08 ET

Antifungals Market to Reach $8.4 Billion by 2016

ROCKVILLE, MD--(Marketwire - Apr 11, 2011) - MarketResearch.com has announced the addition of GBI Research's new report "Antifungals Market to 2016 - Promising Antifungals in Pipeline Includes Novel Azoles, Polyenes and Echinocandin" to their collection of Pharmaceuticals market reports. For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=6207090

GBI Research's analysis showed that the global antifungals market was estimated at $7.4 billion in 2009, with a year-on-year growth rate of 2.3% between 2001 and 2009. The antifungals market is dominated by target therapeutics, which is more efficient and safe when compared to other conventional therapies. GBI Research forecasts that the market will grow at a Compound Annual Growth Rate (CAGR) of 1.9% between 2009 and 2016 to record a sales value of $8.4 billion. The patent expiry of the major drugs has also paved the way for the entry of generic.

GBI Research, a leading business intelligence provider, has released its latest research "Antifungals Market to 2016 - Promising Antifungals in Pipeline Includes Novel Azoles, Polyenes and Echinocandin," which provides insights into antifungals sales and price forecasts until 2016. The report examines global treatment usage patterns of antifungals therapies. The geographical distribution of antifungals therapies across the US, the top five countries in the European region and Japan are also provided in the report. The report includes insights into the antifungals R&D pipeline and potential future blockbusters up to 2016.

The report provides an in-depth analysis of the top three antifungals therapeutic indications, which are aspergillosis, dermatophytosis and candidiasis. It also includes the market forecasts and treatment usage patterns of these three therapeutic indications. The report explores the competitive landscape including top companies benchmarking, and the key trend analysis on Mergers and Acquisitions (M&A) and licensing agreements involving antifungals therapies are also presented. In-depth analysis of the report is based on propriety databases, primary and secondary research and in-house analysis by GBI Research's team of experts.

For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=6207090

Contact Information

  • Contact:
    Veronica Franco
    MarketResearch.com
    Email Contact
    240.747.3016